PAF (C18)

• UNSPSC Description:

  C18-PAF, octadecane PAF, is the ligand of platelet-activating factor and PAF G protein-coupled receptor (PAFR). C18-PAF has renovasodilator properties and antihypertensive lipid properties. C18-PAF increases renal blood flow and causes dose-dependent systemic hypotension[1].

• Target Antigen:

  Platelet-activating Factor Receptor (PAFR)

• Type:

  Biochemical Assay Reagents

• Related Pathways:

  GPCR/G Protein

• Field of Research:

  Cardiovascular Disease

• Assay Protocol:

  https://www.medchemexpress.com/paf-c18.html

• Purity:

  99.00

• Solubility:

  10 mM in DMSO

• Smiles:

  CCCCCCCCCCCCCCCCCCOC[C@@H](OC(C)=O)COP(OCC[N+](C)(C)C)([O-])=O

• Molecular Weight:

  551.74

• References & Citations:

  [1]Vargaftig BB, et al. Background and present status of research on platelet-activating factor (PAF-acether). Ann N Y Acad Sci. 1981;370:119-37.

• Shipping Conditions:

  Blue Ice

• Storage Conditions:

  -20°C, 3 years (Powder)

• Clinical Information:

  No Development Reported

• CAS Number:

  74389-69-8